National Institutes of Health: all 11,571 studies

Page 50 of 116. Open to participants first (946), then studies with results posted, then the rest; newest registration first within each.

• Effects of Systemically Administered Hydrocortisone on the Immune System in Healthy VolunteersCompletedNCT01281995
• (11C)dLop as a Marker of P-Glycoprotein Function in Patients With GliomasTerminatedNCT01281982
• Paclitaxel, Cisplatin, and Veliparib in Treating Patients With Advanced, Persistent, or Recurrent Cervical CancerCompletedNCT01281852Phase 1
• High-Dose or Low-Dose Vorinostat in Combination With Carboplatin or Paclitaxel in Treating Patients With Advanced Solid TumorsActive, not recruitingNCT01281176Phase 1
• Lapatinib Ditosylate and Akt Inhibitor MK2206 in Treating Women With Metastatic Breast CancerTerminatedNCT01281163Phase 1
• Veliparib in Combination With Carboplatin and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid TumorsCompletedNCT01281150Phase 1
• Weekly Doses of Cilengitide and Paclitaxel in Treating Patients With Advanced Solid Tumors That Cannot Be Removed by SurgeryCompletedNCT01276496Phase 1
• CARDIA Brain MRI SubstudyCompletedNCT01273311
• National Epidemiologic Survey on Alcohol and Related Conditions-IIICompletedNCT01273220
• Evaluating Supportive Care for Children With Cancer: A Multi-Institutional Survey Study of Pediatric Oncology Patients and ParentsCompletedNCT01273194
• Endoxifen in Adults With Hormone Receptor Positive Solid TumorsCompletedNCT01273168Phase 1
• Lenalidomide in Treating Patients With High-Risk Chronic Lymphocytic LeukemiaWithdrawnNCT01271283Phase 2
• Palomid 529 in Patients With Neovascular Age-Related Macular DegenerationCompletedNCT01271270Phase 1
• Combination Chemotherapy and Bevacizumab With or Without RO4929097 in Treating Patients With Metastatic Colorectal CancerWithdrawnNCT01270438Phase 2
• RO4929097 in Treating Patients With Recurrent Invasive GliomasTerminatedNCT01269411Phase 1
• Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected AdultsCompletedNCT01266616Phase 1
• Malaria Surveillance in Rakai, UgandaCompletedNCT01265407
• Thyroid Cancer Among Chornobyl Clean-up Workers in Ukraine: Pilot StudyTerminatedNCT01265381
• Veliparib and Radiation Therapy in Treating Patients With Advanced Solid Malignancies With Peritoneal Carcinomatosis, Epithelial Ovarian, Fallopian, or Primary Peritoneal CancerCompletedNCT01264432Phase 1
• Cross-sectional Characterization of Idiopathic BronchiectasisCompletedNCT01264055
• Efficacy of Mindful Tai Chi on Obese or Overweight Adults: A Randomized Controlled Clinical TrialTerminatedNCT01264029Phase 2
• MK2206 and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Metastatic Breast CancerCompletedNCT01263145Phase 1
• Evaluation of Influenza-Specific Immune Responses in Children and Adults During the 2010-2011 Influenza Season in the U.S.CompletedNCT01262079
• Effects of Lifeskills Workshop on BP in Hypertensive EmployeesCompletedNCT01262066Phase 2
• The Effect of Transcranial Magnetic Stimulation on Learning With Reward in Healthy HumansTerminatedNCT01260740
• Evaluating the Safety of and Immune Response to an HIV Vaccine Followed by Booster, Administered by Two Devices, in HIV-Uninfected AdultsCompletedNCT01260727Phase 1
• Azacitidine, Mitoxantrone Hydrochloride, and Etoposide in Treating Older Patients With Poor-Prognosis Acute Myeloid LeukemiaTerminatedNCT01260714Phase 1
• Satraplatin in Children and Young Adults With Refractory Solid Tumors Including Brain TumorsCompletedNCT01259479Phase 1
• Tumor Cell Vaccines With ISCOMATRIX Adjuvant and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers and Malignant Pleural MesotheliomasTerminatedNCT01258868Phase 1
• Environmental and Genetic Determinants of NPCTerminatedNCT01257100
• Parent Supported Weight Reduction in Down SyndromeCompletedNCT01256112Not applicable
• Evaluation of the Safety and Immunogenicity of a Live Attenuated Human Metapneumovirus VaccineCompletedNCT01255410Phase 1
• Frequency of EGFR Mutations in Latinos/Hispanics With Non-Small Cell Lung CancerCompletedNCT01255150
• Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck CancerCompletedNCT01254617Phase 1
• Lenalidomide After Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic CancersCompletedNCT01254578Phase 1
• Evaluating the Safety and Immunogenicity of a Human Parainfluenza Type 3 (HPIV3) Virus Vaccine in Infants and ChildrenCompletedNCT01254175Phase 1
• Mobility Training to Improve Motor Behavior in Toddlers With or at Risk for Cerebral Palsy: A Pilot StudyCompletedNCT01253083Phase 1
• EZN-2208 (Pegylated SN-38) in Combination With Bevacizumab in Refractory Solid TumorsCompletedNCT01251926Phase 1
• A Pilot Study of Inpatient Hospice With Procurement of Brain Tumor Tissue on Expiration for Research PurposesTerminatedNCT01251913
• BRCA Mutations in LatinasCompletedNCT01251900
• Veliparib and Carboplatin in Treating Patients With HER2-Negative Metastatic Breast CancerActive, not recruitingNCT01251874Phase 1
• RO4929097 After Autologous Stem Cell Transplant in Treating Patients With Multiple MyelomaWithdrawnNCT01251172Phase 2
• Azacitidine in Combination With Mitoxantrone, Etoposide Phosphate, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaCompletedNCT01249430Phase 1
• Nicotinic Receptor Density in Smoking and Nonsmoking SchizophrenicsWithdrawnNCT01246128
• AT13387 in Adults With Refractory Solid TumorsCompletedNCT01246102Phase 1
• Akt Inhibitor MK2206 in Combination With Lapatinib Ditosylate in Patients With Advanced or Metastatic Solid Tumors or Breast CancerCompletedNCT01245205Phase 1
• Sunitinib Malate and Bevacizumab in Treating Patients With Kidney Cancer or Advanced Solid MalignanciesCompletedNCT01243359Phase 1
• Nicotinic Modulation of the Default Network of Resting Brain FunctionCompletedNCT01240616
• Plasmodium Falciparum Clearance Rates in Response to Artesunate in Eastern CambodiaCompletedNCT01240603
• An Early Phase I Study of IPdR Absorption, Metabolism, and Safety in Patients With Advanced Solid Tumors and LymphomasCompletedNCT01240577Phase 1
• Viral Therapy in Treating Young Patients With Relapsed or Refractory Solid TumorsCompletedNCT01240538Phase 1
• Obatoclax Mesylate, Rituximab, and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory Non-Hodgkin LymphomaWithdrawnNCT01238146Phase 1/2
• Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097, Paclitaxel, and Carboplatin Before Surgery in Treating Patients With Stage II or Stage III Triple-Negative Breast CancerTerminatedNCT01238133Phase 1
• Developing Biomarkers of Dietary IntakeCompletedNCT01237093Phase 1
• Olaparib in Combination With Carboplatin for Refractory or Recurrent Women s CancersCompletedNCT01237067Phase 1
• RO4929097 in Children With Relapsed/Refractory Solid or CNS Tumors, Lymphoma, or T-Cell LeukemiaWithdrawnNCT01236586Phase 1
• Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid TumorsTerminatedNCT01233505Phase 1
• Low-Cost Molecular Cervical Cancer Screening StudyCompletedNCT01231945
• Characterizing Fatigue Experienced by Cancer Patients Receiving Primary Treatment and Cancer SurvivorsTerminatedNCT01231932
• MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or LeukemiaCompletedNCT01231919Phase 1
• Automated Prize-based Contingency Management to Increase Counseling Attendance in Opiate-Replacement-Therapy PatientsCompletedNCT01229163Early Phase 1
• Water Deprivation ProtocolCompletedNCT01224704Not applicable
• TGF-(Beta) and Susceptibility to RSVCompletedNCT01224691
• A Comparative Feasibility Study to Assess the Prevalence and Severity of Dental Caries in Incarcerated People Who Abuse MethamphetamineWithdrawnNCT01224002
• Pilot Study of Repetitive Transcranial Magnetic Stimulation in Cocaine CravingWithdrawnNCT01222806Phase 1
• Effects of Antipsychotics on Eating and Food Craving in People With SchizophreniaCompletedNCT01222793
• Lenalidomide and Radiation Therapy in High Grade Gliomas or Diffuse Intrinsic Pontine GliomasCompletedNCT01222754Phase 1
• Using Positron Emission Tomography to Predict Intracranial Tumor Growth in Neurofibromatosis Type II PatientsCompletedNCT01222728
• A Comparison of Methods for Assisting Needle Angle Selection During Image-guided Tissue BiopsyCompletedNCT01218854Phase 1
• Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced Solid TumorsCompletedNCT01218620Phase 1
• Selumetinib and Cetuximab in Treating Patients With Refractory Solid TumorsCompletedNCT01217450Phase 1
• RO4929097 in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma That Can Be Removed by SurgeryWithdrawnNCT01216787Phase 2
• Assessment of Cannabis Craving in Schizophrenia Using Virtual RealityCompletedNCT01212081
• Connectivity Analysis for Investigation of Auditory Impairment in EpilepsyTerminatedNCT01212068
• Multiplex Microarray Chip-Based Diagnosis of Respiratory InfectionsTerminatedNCT01212042
• Immunopathogenesis of Food Allergy and Eosinophilic Gastrointestinal DisordersTerminatedNCT01212016
• An Exploratory Study of the Characteristics of and Challenges for International Families Seeking Medical Care in the United StatesCompletedNCT01211990
• A Pilot Study of XOMA 052 in Familial Cold Autoinflammatory Syndrome / Muckle-Wells Syndrome and Behcet's DiseaseWithdrawnNCT01211977Phase 1/2
• Safety, Tolerability and Efficacy of the Nicotine Patch and Gum for the Treatment of Adolescent Tobacco DependenceCompletedNCT01208935Phase 2/3
• Vorinostat and Isotretinoin in Treating Patients With High-Risk Refractory or Recurrent NeuroblastomaCompletedNCT01208454Phase 1
• RO4929097 and Letrozole in Treating Post-Menopausal Women With Hormone Receptor-Positive Stage II or Stage III Breast CancerTerminatedNCT01208441Phase 1
• Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine CarcinomaCompletedNCT01204476Phase 1
• A Study of the Pharmacology of Tamiflu in PregnancyCompletedNCT01203527
• Assessment of Alterations in Immune Function During Pregnancy and Post ParturitionCompletedNCT01200979
• Ethanol Response in Essential Tremor: Clinical and Neurophysiological CorrelatesCompletedNCT01200966
• Metabolic Effects of Non-Nutritive SweetenersCompletedNCT01200940Phase 1/2
• Effects of Rosuvastatin on the Immune System in Healthy Volunteers With Normal CholesterolCompletedNCT01200836
• Collection of Blood, Bone Marrow, Leukapheresis, and Tissue Biopsy Samples From Patients and Their Family Members for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases Laboratory Research StudiesTerminatedNCT01200823
• Genetic Clues to Chordoma Etiology: A Protocol to Identify Sporadic Chordoma Patients for Studies of Cancer-Susceptibility GenesActive, not recruitingNCT01200680
• Phase I Study of Cetuximab With RO4929097 in Metastatic Colorectal CancerTerminatedNCT01198535Phase 1
• PET Brain and Whole Body Distribution Studies for Nociceptin/Orphanin FQ Peptide (NOP) Receptor Using [11C]NOP-1ACompletedNCT01198197Early Phase 1
• Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 and Temsirolimus in Treating Patients With Advanced Solid TumorsCompletedNCT01198184Phase 1
• Epidemiology of Burkitt Lymphoma in East Africa Children or Minors (EMBLEM)CompletedNCT01196520
• Facilitating Numerical Processing With Transcranial Stimulation in Developmental DyscalculiaWithdrawnNCT01195961
• Reproducibility of a Fecal Occult Blood Test Device for Gut Microbiota AnalysesCompletedNCT01194687
• Neural Dynamics and Connectivity in Response Inhibition and Traumatic Brain InjuryCompletedNCT01194661
• RO4929097 and Erlotinib Hydrochloride in Treating Patients With Stage IV or Recurrent Non-small Cell Lung CancerTerminatedNCT01193881Phase 1
• The Healthy Families ProjectCompletedNCT01193374Not applicable
• RO4929097 Before Surgery in Treating Patients With Pancreatic CancerTerminatedNCT01192763Phase 1
• Cellular and Molecular Characterization of the Immune Response in Healthy NIH Employees atBaseline, and After Immunization With the H1N1 or Seasonal Influenza VaccinesCompletedNCT01191853

← National Institutes of Health overview and focus areas